Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-27

Clinical Trial Update: Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment [Phase 4]

View source ↗

Summary

Phase 4 diagnostic accuracy study evaluating indocyanine green for assessing parathyroid perfusion in thyroid surgery is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Thyroid Cancer, Thyroid Goiter | Phase 4 | Status: COMPLETED